Friday, 30 December 2016

News at Gilead Is Better but Not Good

A slowing decline in prescriptions is a positive development for the battered biotech

from WSJ.com: Markets http://ift.tt/2hCwdiN
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)